470 related articles for article (PubMed ID: 3838767)
1. Inhibition of bone marrow colony formation by human natural killer cells and by natural killer cell-derived colony-inhibiting activity.
Degliantoni G; Perussia B; Mangoni L; Trinchieri G
J Exp Med; 1985 May; 161(5):1152-68. PubMed ID: 3838767
[TBL] [Abstract][Full Text] [Related]
2. Natural killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor. Relationship with tumor necrosis factor and synergism with immune interferon.
Degliantoni G; Murphy M; Kobayashi M; Francis MK; Perussia B; Trinchieri G
J Exp Med; 1985 Nov; 162(5):1512-30. PubMed ID: 3932579
[TBL] [Abstract][Full Text] [Related]
3. The effect of natural killer cells on the development of syngeneic hematopoietic progenitors.
Holmberg LA; Miller BA; Ault KA
J Immunol; 1984 Dec; 133(6):2933-9. PubMed ID: 6436368
[TBL] [Abstract][Full Text] [Related]
4. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
Wisniewski D; Strife A; Atzpodien J; Clarkson BD
Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow natural suppressor cells inhibit the growth of myeloid progenitor cells and the synthesis of colony-stimulating factors.
Moore SC; Theus SA; Barnett JB; Soderberg LS
Exp Hematol; 1992 Nov; 20(10):1178-83. PubMed ID: 1426097
[TBL] [Abstract][Full Text] [Related]
6. Characterization of adult human marrow hematopoietic progenitors highly enriched by two-color cell sorting with My10 and major histocompatibility class II monoclonal antibodies.
Lu L; Walker D; Broxmeyer HE; Hoffman R; Hu W; Walker E
J Immunol; 1987 Sep; 139(6):1823-9. PubMed ID: 3114377
[TBL] [Abstract][Full Text] [Related]
7. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
8. Suppression of normal human hematopoiesis by cytomegalovirus in vitro.
MacKintosh FR; Adlish J; Hall SW; St Jeor S; Smith E; Tavassoli M; Zanjani ED
Exp Hematol; 1993 Feb; 21(2):243-50. PubMed ID: 8381087
[TBL] [Abstract][Full Text] [Related]
9. Production of colony-stimulating factor(s) for granulocyte-macrophage and multipotential (granulocyte/erythroid/megakaryocyte/macrophage) hematopoietic progenitor cells (CFU-GEMM) by clonal lines of human IL-2-dependent T-lymphocytes.
Greenberger JS; Krensky AM; Messner H; Burakoff SJ; Wandl U; Sakakeeny MA
Exp Hematol; 1984 Oct; 12(9):720-7. PubMed ID: 6333354
[TBL] [Abstract][Full Text] [Related]
10. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
Broxmeyer HE; Williams DE; Lu L; Cooper S; Anderson SL; Beyer GS; Hoffman R; Rubin BY
J Immunol; 1986 Jun; 136(12):4487-95. PubMed ID: 3086433
[TBL] [Abstract][Full Text] [Related]
11. Effect of deoxycytidine on 2-chloro-deoxyadenosine-mediated growth inhibition of normal human erythroid and myeloid progenitor cells.
Bilgeri R; Petzer AL; Zilian U; Geisen FH; Schirmer M; Haun M; Konwalinka G
Exp Hematol; 1993 Mar; 21(3):432-7. PubMed ID: 8095026
[TBL] [Abstract][Full Text] [Related]
12. Production of colony-stimulating activity by human natural killer cells: analysis of the conditions that influence the release and detection of colony-stimulating activity.
Pistoia V; Zupo S; Corcione A; Roncella S; Matera L; Ghio R; Ferrarini M
Blood; 1989 Jul; 74(1):156-64. PubMed ID: 2502200
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
[TBL] [Abstract][Full Text] [Related]
14. Human thymic epithelial cells produce granulocyte and macrophage colony-stimulating factors.
Le PT; Kurtzberg J; Brandt SJ; Niedel JE; Haynes BF; Singer KH
J Immunol; 1988 Aug; 141(4):1211-7. PubMed ID: 2456345
[TBL] [Abstract][Full Text] [Related]
15. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
Lemoli RM; Gulati SC
Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
[TBL] [Abstract][Full Text] [Related]
16. Suppressive biological activity of a synthetic pentapeptide on highly enriched human and murine marrow hematopoietic progenitors: synergism with recombinant human tumor necrosis factor-alpha and interferon-gamma.
Lu L; Foa P; Chillemi F; Shen RN; Lin ZH; Carow C; Broxmeyer HE
Exp Hematol; 1989 Oct; 17(9):935-41. PubMed ID: 2506072
[TBL] [Abstract][Full Text] [Related]
17. In vivo function of natural killer cells as regulators of myeloid precursor cells in the spleen.
Hansson M; Petersson M; Koo GC; Wigzell H; Kiessling R
Eur J Immunol; 1988 Mar; 18(3):485-8. PubMed ID: 3258567
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells.
Broxmeyer HE; Lu L; Platzer E; Feit C; Juliano L; Rubin BY
J Immunol; 1983 Sep; 131(3):1300-5. PubMed ID: 6193183
[TBL] [Abstract][Full Text] [Related]
19. Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults.
Broxmeyer HE; Hangoc G; Cooper S; Ribeiro RC; Graves V; Yoder M; Wagner J; Vadhan-Raj S; Benninger L; Rubinstein P
Proc Natl Acad Sci U S A; 1992 May; 89(9):4109-13. PubMed ID: 1373894
[TBL] [Abstract][Full Text] [Related]
20. Lymphokine-activated killer cells selectively kill tumor cells in bone marrow without compromising bone marrow stem cell function in vitro.
van den Brink MR; Voogt PJ; Marijt WA; van Luxemburg-Heys SA; van Rood JJ; Brand A
Blood; 1989 Jul; 74(1):354-60. PubMed ID: 2787676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
